NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) ? Neuroendocrine and Adrenal Tumors Version 4.2018 — January 07, 2019 NCCN Guidelines for Patients available at www.nccn/patients ? NCCN Continue Version 4.2018, 01/07/19 ? National Comprehensive Cancer Network, Inc. 2019, All rights reserved. The NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN . ? ? Printed by Maria Chen on 1/7/2019 8:58:29 PM. For personal use only. Not approved for distribution. Copyright ? 2019 National Comprehensive Cancer Network, Inc., All Rights Reserved. NCCN Guidelines Version 4.2018 Neuroendocrine and Adrenal Tumors NCCN Guidelines Index Table of Contents Discussion *Manisha H. Shah, MD/Chair ? The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Paul Fanta, MD ? UC San Diego Moores Cancer Center Stanford Cancer Institute Pamela L. Kunz, MD ? Jonathan R. Strosberg, MD ? Mo?tt Cancer Center Thomas Giordano, MD, PhD ≠ University of Michigan Comprehensive Cancer Center Boris W. Kuvshino?, II, MD, MBA ? Roswell Park Comprehensive Cancer Center Craig A. Sussman, MD T Vanderbilt-Ingram Cancer Center Matthew H. Kulke, MD/Chair ? Dana-Farber/Brigham and Women’s Cancer Center Thorvardur R. Halfdanarson, MD T ? Mayo Clinic Cancer Center Christopher Lieu, MD ? University of Colorado Cancer Center Nikolaos A. Trikalinos, MD ? Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine Daniel Halperin, MD ? The University of Texas MD Anderson Cancer Center *Whitney S. Goldner, MD/Vice Chair e Fred & Pamela Bu?ett Cancer Center Rob